Lifetime and Treatment-Phase Costs Associated With Colorectal Cancer: Evidence from SEER-Medicare Data
- 28 February 2009
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 7 (2) , 198-204
- https://doi.org/10.1016/j.cgh.2008.08.034
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysisGastroenterology, 2004
- National estimates of medical costs incurred by nonelderly cancer patientsCancer, 2004
- Overview of the SEER-Medicare DataMedical Care, 2002
- Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare DataMedical Care, 2002
- Lifetime cancer-attributable cost of care for long term survivors of colorectal cancerAmerican Journal of Gastroenterology, 2002
- The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case studyHealth Economics, 2001
- Cost-effectiveness of Screening for Colorectal Cancer in the General PopulationJAMA, 2000
- Obtaining Long-Term Disease Specific Costs of CareMedical Care, 1999
- Estimating the costs attributable to a disease with application to ovarian cancerJournal of Clinical Epidemiology, 1996
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992